Trials / Completed
CompletedNCT00051168
A Long-term Safety Study of Once-daily Travatan
A Long-term Safety Study of Once-daily TRAVATAN
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 502 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Travatan | Travoprost (0.004%) 1 drop each eye once daily |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2009-03-01
- First posted
- 2003-01-07
- Last updated
- 2011-10-07
- Results posted
- 2010-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00051168. Inclusion in this directory is not an endorsement.